 NEW YORK, Jan. 05, 2021 GLOBE NEWSWIRE -- Intra-Cellular Therapies, Inc. Nasdaq:ITCI, a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system CNS disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 9:10 am ET. 